Free Ground Shipping on all orders of $100 or more, or 50% off shipping on all orders under $100.

Resources

Subscribe to RSS Feed

CBD In The News


CBD Goes Mainstream

Consumer Reports surveyed more than 1000 people to see the effects of CBD in their lives.

https://www.consumerreports.org/cbd/cbd-goes-mainstream/

CBD Enhances Fracture Healing

CBD studies show that the compound can help heal bone fractures and accelerate the process.

https://www.labroots.com/trending/cannabis-sciences/8584/cannabidiol-enhances-fracture-healing

CBD Poised for Boom After Farm Bill

CBD industry is calling this bill a "game changer."

https://www.rollingstone.com/culture/culture-features/cbd-farm-bill-legalization-marijuana-hemp-769944/

Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds

Agriculture Improvement Act of 2018 was signed into law.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm628988.htm

Farm bill headed to Trump after landslide House approval

The house passes farm bill

https://www.politico.com/story/2018/12/12/house-passes-farm-bill-1060916

Senate, Rejecting Curbs on Food Stamps, Passes Compromise Farm Bill

CBD could be grown more locally

https://www.nytimes.com/2018/12/11/us/politics/farm-bill-compromise-senate.html

Why Is CBD Everywhere?

From endorsements from Medical professionals and more, CBD may be the solution you need.

https://www.nytimes.com/2018/10/27/style/cb

Anxiety Relief without the High? New Studies on CBD, A Cannabis Extract

NPR takes alook at how CBD is being used to treat anxiety.

https://www.npr.org/sections/health-shots/2018/04/23/604307015/anxiety-relief-without-the-high-new-studies-on-cbd-a-cannabis-extract

New Report Predicts CBD Market Will Hit $22 Billion by 2022

The CBD Market has the potential to reach $22 billion by 2022

https://www.rollingstone.com/culture/culture-news/new-study-cbd-market-22-billion-2022-722852/

DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access

The U.S. Drug Enforcement Administration has taken some Cannabidiol off the most restrictive class of controlled substances. As long as its FDA approved.

https://mjbizdaily.com/dea-moves-cbd-medicines-off-schedule-1-a-limited-expansion-of-cannabis-access/

Read more CBD In The News



Selected CBD Research


Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis

Journal of Pharmacology and Experimental Therapeutics, June 2018

CBD tamps down the immune system’s overreaction in the skin when someone comes in contact with an allergen.

http://jpet.aspetjournals.org/content/365/3/652

US FDA Approves GW Pharmaceuticals' Epidolex to Treat Epilepsy

NEJM, May 2017

It was recently approved by the FDA as an epilepsy medicine for children.

https://www.nejm.org/doi/full/10.1056/NEJMoa1611618?query=featured_home

Read more Selected CBD Research

CBD products made from industrial hemp are legal within the U.S. as long as they contain less than 0.3% THC. Our products are legal for sale and use in any state and without a prescription.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
This product is not for use by or sale to persons under the age of 21. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult with a physician before use if you have a serious medical condition or use prescription medications. A Doctor's advice should be sought before using this and any supplemental dietary product. All trademarks and copyrights are the property of their respective owners and are not affiliated with nor do they endorse this product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Individual weight loss results will vary.

By using this site, you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void Where Prohibited by Law.

NOT FOR SALE TO PERSONS UNDER THE AGE OF 21

Powered by iMobileApp